HDFC ERGO Shares Post-Pandemic Insights on Health Insurance: Global Lessons for Coverage and Risk

HDFC ERGO Shares Post-Pandemic Insights on Health Insurance: Global Lessons for Coverage and Risk GlobeNewswire December 09, 2025 Mumbai, India, Dec. 09, 2025 (GLOBE NEWSWIRE) — The pandemic made many families look at money and medical care in a very different way. Hospital bills, medicine costs and the stress of sudden illness showed how fragile

NUS scientists create microneedle system to deliver biofertiliser directly into plants, boosting growth with less waste

A dissolving patch delivers beneficial microbes into leaves and stems, speeding growth in vegetables while using over 15 per cent less biofertiliser than soil application Researchers at the National University of Singapore (NUS) have developed dissolving microneedle patches that deliver living “biofertiliser” straight into plant tissue. In greenhouse tests, Choy Sum and Kale grew faster

Bezos Earth Fund Announces $24.5 Million for Coastal Protection and Stewardship Across the Eastern Tropical Pacific

WASHINGTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — The Bezos Earth Fund today announced $24.5 million in grants to help park rangers, coastal communities, and local organizations protect key marine areas across the Eastern Tropical Pacific. The new funding will improve on-the-water safety and planning, expand community-led protection in nursery habitats, and strengthen the science used

Bezos Earth Fund Announces $24.5 Million for Coastal Protection and Stewardship Across the Eastern Tropical Pacific

Bezos Earth Fund Announces $24.5 Million for Coastal Protection and Stewardship Across the Eastern Tropical Pacific New grants support community-led stewardship and advance science-driven decision-making across Costa Rica, Panama, Colombia and Ecuador GlobeNewswire December 09, 2025 WASHINGTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — The Bezos Earth Fund today announced $24.5 million in grants to help

Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases

LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases. Under the terms of the agreement, Relation will receive $55 million, comprising an upfront payment, equity investment and additional R&D funding. In addition, Relation is eligible to receive preclinical, development,

Actimed Therapeutics to Highlight Advancing Clinical Pipeline with New Data Presentations at 18th Annual Conference on Sarcopenia, Cachexia, and Wasting Disorders

London, UK – 9th December 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, will once again support the International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders (SCWD) taking place in Rome, Italy

Relation announces further $26 million investment

LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Relation today announced a further $26 million investment from existing investors NVentures (NVIDIA's venture capital arm) and leading deeptech investors DCVC and Magnetic Ventures. “Relation's unique combination of computation, experimentation, and patient data will reduce failure rates in drug development and transform the way we treat common, devastating

Imec demonstrates first wafer-scale fabrication of solid-state nanopores using EUV lithography

Breakthrough enables scalable, high-precision biosensing applications in life sciences and healthcare https://mma.prnewswire.com/media/2839859/imec_Logo.jpg — Imec has achieved the first successful wafer-scale fabrication of solid-state nanopores using EUV lithography on 300mm wafers. This innovation transforms nanopore technology from a lab-scale concept into a scalable platform for biosensing, genomics and proteomics. — Nanopores are hailed as gamechangers for

Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases

Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases GlobeNewswire December 09, 2025 LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases. Under the terms of the agreement, Relation will receive $55 million, comprising an upfront

Scroll to Top